AGIO
Agios Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$40.06+1.14%
Price as of Jul 20, 2026
AGIO capital
Agios Pharmaceuticals, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.07x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.09x
- Net debt / EBITDA
- 0.19x
Liquidity & coverage
- Current ratio
- 14.19x
- Quick ratio
- 13.59x
- Cash ratio
- 12.53x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $776.0M
Cash & dividend
- FCF / debt
- -10.76x
- Cash flow / debt
- -10.64x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.